User profiles for Francisco Leyva
Francisco LeyvaProfessor of Cardiology Verified email at uhb.nhs.uk Cited by 23974 |
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization …
for digital applications (smartphones, etc.). These versions are abridged and thus, for more
detailed information, the user should always access to the full text version of the guidelines, …
detailed information, the user should always access to the full text version of the guidelines, …
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and …
… Lewis (Israel), Francisco Leyva (United Kingdom), AleVs Linhart (Czech Republic), Maja‐Lisa
Løchen (Norway), Lars H. Lund (Sweden), Donna Mancini (United States of America), …
Løchen (Norway), Lars H. Lund (Sweden), Donna Mancini (United States of America), …
Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging
…, W Doehner, M Rauchhaus, R Sharma, D Francis… - Circulation, 2003 - Am Heart Assoc
Background— Serum uric acid (UA) could be a valid prognostic marker and useful for
metabolic, hemodynamic, and functional (MFH) staging in chronic heart failure (CHF). Methods …
metabolic, hemodynamic, and functional (MFH) staging in chronic heart failure (CHF). Methods …
Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure
…, C Walton, IF Godsland, AL Clark, F Leyva… - Journal of the American …, 1997 - jacc.org
Objectives. We attempted to assess insulin sensitivity in patients with chronic heart failure (CHF)
and its relation to disease severity. Background. Peripheral muscular changes influence …
and its relation to disease severity. Background. Peripheral muscular changes influence …
The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular …
…, F Wenzelburger, E Lee, G Heatlie, F Leyva… - Journal of the American …, 2009 - jacc.org
Objectives : The purpose of this study was to test the hypothesis that in heart failure with
normal ejection fraction (HFNEF) exercise limitation is due to combined systolic and diastolic …
normal ejection fraction (HFNEF) exercise limitation is due to combined systolic and diastolic …
Uric acid in chronic heart failure: a marker of chronic inflammation
Background Chronic heart failure is associated with hyperuricaemia and elevations in
circulating markers of inflammation. Activation of xanthine oxidase, through free radical release, …
circulating markers of inflammation. Activation of xanthine oxidase, through free radical release, …
Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk
F Leyva, IF Godsland, M Ghatei… - … , and vascular biology, 1998 - Am Heart Assoc
In humans, production of the adipocyte-derived peptide leptin has been linked to adiposity,
insulin, and insulin sensitivity. We therefore considered that alterations in plasma leptin …
insulin, and insulin sensitivity. We therefore considered that alterations in plasma leptin …
Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis
Objectives : The aim of this study was to evaluate the association between late gadolinium
enhancement (LGE) on cardiac magnetic resonance imaging and ventricular arrhythmias or …
enhancement (LGE) on cardiac magnetic resonance imaging and ventricular arrhythmias or …
Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure
…, S von Haehling, DO Okonko, F Leyva… - Journal of the American …, 2005 - jacc.org
Objectives : The aim of this study was to determine the significance of insulin resistance as
an independent risk factor for impaired prognosis in patients with chronic heart failure (CHF). …
an independent risk factor for impaired prognosis in patients with chronic heart failure (CHF). …
Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy
Objectives : The aim of this study was to determine whether left ventricular (LV) midwall
fibrosis, detected by midwall hyperenhancement (MWHE) on late gadolinium enhancement …
fibrosis, detected by midwall hyperenhancement (MWHE) on late gadolinium enhancement …